Shuichi Takayama
Georgia Institute of Technology
394 Papers
4.1K Citations
Shuichi Takayama is an academic researcher from Georgia Institute of Technology. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 77, co-authored 361 publications. Previous affiliations of Shuichi Takayama include Parker H. Petit Institute for Bioengineering & Bioscience & Ulsan National Institute of Science and Technology.
Chat about Author
Papers
Gravity-Driven Micropump with a Steady Flow Rate
Xiaoyue Zhu,Nandita Phadke,Joseph Chang,Brenda S. Cho,Dongeun Huh,Shuichi Takayama +5 more
- 01 Jan 2002
TL;DR: The MIcrofluidic gravity pump (MIG-pump) as discussed by the authors can deliver fluid at a steady flow rate over extended periods of time using horizontally oriented reservoirs, which allow a constant hydraulic pressure to be maintained between the inlet and outlet.
7
Aqueous two-phase deposition and fibrinolysis of fibroblast-laden fibrin micro-scaffolds.
TL;DR: In this article, aqueous two-phase approach was used to print micro-scale fibroblast-laden matrices using an annealing approach that controlled thrombin-mediated enzymatic crosslinking of fibrin.
7
Guided corona generates wettability patterns that selectively direct cell attachment inside closed microchannels.
Angela R. Dixon,Shuichi Takayama +1 more
TL;DR: A method to create plasma mediated linear protein patterns along the lengths of simple one-inlet-one-outlet straight polydimethylsiloxane microchannels by biasing the delivery of corona discharge at the capillary openings is presented.
7
Patent
Systems and methods for multiplex solution assays
Arlyne Simon,John P. Frampton,Josh White,Shuichi Takayama +3 more
- 14 Jun 2013
TL;DR: In this article, a 2-phase system droplet array is described and methods for performing multiplexed assays, chemical, and/or biological experiments and tests (e.g., immunoassays).
7
Kampo Medicine Promotes Early Recovery From Coronavirus Disease 2019-Related Olfactory Dysfunction: A Retrospective Observational Study
Rie Ono,Ryutaro Arita,Shuichi Takayama,Akiko Kikuchi,Minoru Ohsawa,Natsumi Saito,Satoko Suzuki,Tadashi Ishii +7 more
TL;DR: This study suggests that Kampo medication promotes early recovery from coronavirus disease 2019-related olfactory dysfunction and multiple logistic regression analysis demonstrated that only Kampo treatment was significantly associated with improvement in olf factory dysfunction.